Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMR-based Metabolic Profiling Identifies High Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients With Advanced Fibrosis: An Observational, Multi-center Study

NCT05734599 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT05734599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05734599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMR-based Metabolic Profiling Identifies High Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients With Advanced Fibrosis: An Observational, Multi-center Study
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
May 1, 2024
Enrollment
1,194 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease, metabolic dysfunction-associated fatty liver disease